REQUEST A DEMO
Total
USD $0.00
Search more companies

Laboratorios Biotek S.A.S. (Colombia)

Main Activities: Miscellaneous Nondurable Goods Merchant Wholesalers
Secondary Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Laboratorios Biotek S.A.S. Profile Updated: May 21, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Laboratorios Biotek S.A.S. is based in Colombia, with the head office in Cali. It operates in the Miscellaneous Nondurable Goods Merchant Wholesalers industry. Laboratorios Biotek S.A.S. was incorporated on September 11, 2014. The total number of employees is currently 21 (2024). From the latest financial highlights, Laboratorios Biotek S.A.S. reported a net sales revenue increase of 14.61% in 2023. There was a total growth of 25.98% in Laboratorios Biotek S.A.S.’s total assets over the same period. In 2023, Laboratorios Biotek S.A.S.’s net profit margin decreased by 2.36%.

Headquarters
Kr 85 # 14 A - 85 Brr El Ingenio
Cali; Valle del Cauca;

Contact Details: Purchase the Laboratorios Biotek S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Laboratorios Biotek S.A.S. report to view the information.
Outstanding Shares:
Purchase the Laboratorios Biotek S.A.S. report to view the information.
Incorporation Date:
September 11, 2014
Key Executives
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Laboratorios Biotek S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
14.61%
Total operating revenue
14.61%
Operating profit (EBIT)
9.59%
Net Profit (Loss) for the Period
-41.2%
Total assets
25.98%
Total equity
14.82%
Operating Profit Margin (ROS)
-0.37%
Net Profit Margin
-2.36%
Return on Equity (ROE)
-12.29%
Quick Ratio
0.13%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?